Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Skeletal muscle metabolism refers to the complex network of biochemical pathways that govern how skeletal muscle fibers generate and utilize energy. These processes include oxidative phosphorylation and glycolysis for ATP production, as well as lipid and amino acid metabolism. Skeletal muscle is composed of heterogeneous fiber types—primarily slow-twitch (type I) fibers that rely on oxidative metabolism for sustained activity, and fast-twitch fibers (type IIa/IIx/IIb) with varying capacities for glycolytic or oxidative energy production[2][3][5]. The metabolic profile of each fiber type determines its function in movement and endurance. Regulation of skeletal muscle metabolism is critical for adaptation to exercise, growth efficiency, nutrient utilization, protein turnover rate, and overall metabolic health[2][3]. Dysregulation can contribute to diseases such as insulin resistance or muscular atrophy. Additional notes: "Skeletal muscle metabolism" is not a specific molecule or receptor but rather a physiological process involving many enzymes, transporters, receptors, signaling molecules, and structural proteins[2][4]. Therefore: • It is not considered a canonical therapeutic target like an enzyme or receptor. • There are no standard aliases; it describes a functional system. • No direct interacting drugs exist; however, many drugs indirectly affect skeletal muscle metabolism by targeting upstream regulators or pathways. • Biomarkers such as acylcarnitines may be used in research settings to monitor changes in metabolic state[1]. • Safety concerns are context-dependent based on interventions affecting this system. If you require information about specific molecular targets within skeletal muscle metabolism—such as AMP‐activated protein kinase (AMPK), peroxisome proliferator–activated receptor gamma coactivator 1-alpha (PGC‐1α), or glucose transporter type 4—you should specify the particular molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Skeletal muscle metabolism.